The Morning Call
A significant breakthrough may have been recorded in the search for effective treatment and cure for the deadly HIV virus. Scientists say a new HIV vaccine candidate has been trialled in humans and monkeys, with promising results.
Nearly 400 healthy, uninfected adults are reported to have mounted an immune response against the vaccine and tolerated it well, according to the latest study published in The Lancet.
It’s a quest that’s been nearly 40 years in the making. Lead researcher Dan Barouch from Harvard Medical School said the study was an “important milestone” in HIV research, but that the results should be interpreted with caution.
So are we one step closer to finding effective treatment for HIV?
01:03
Ebola: DRC receives shipment of more than 16,000 vaccine doses
00:59
DRC Ebola outbreak growing 'exponentially,' UN warns, as deaths exceed 2,500
01:14
DR Congo receives 70,000 Ebola vaccine doses for outbreak response
01:53
Thousands watch partial solar eclipse in north of Algeria
00:48
First person vaccinated during trial of new Ebola jab
01:51
UNAIDS warns funding cuts threaten progress to eliminate HIV/AIDS